|8-KJan 30, 3:39 PM ET

Cannabist Co Holdings Inc. 8-K

Research Summary

AI-generated summary

Updated

Cannabist Co Holdings Inc. Announces Qualified Partial Redemption of Notes

What Happened
Cannabist Co Holdings Inc. filed an 8-K (Jan 30, 2026) reporting that on Jan 29, 2026 it issued a qualified partial redemption notice to holders of its 9.25% Senior Secured Notes due 2028 and its 9.00% Senior Secured Convertible Notes due 2028. The redemption price is 100% of principal plus accrued but unpaid interest to, but excluding, the redemption date. The partial redemptions are conditioned on completion of a previously announced equity purchase agreement dated Dec 18, 2025 involving Green Leaf Medical of Virginia, LLC; Green Leaf Medical, LLC; Parma Holdco LLC; and Millstreet Credit Fund LP. The notice will become null and void if the condition is not satisfied within 60 days of Jan 29, 2026.

Key Details

  • Redemption instruments: 9.25% Senior Secured Notes due 2028 and 9.00% Senior Secured Convertible Notes due 2028, issued under the May 29, 2025 indenture with Odyssey Trust Company as trustee.
  • If the condition is satisfied on or before Feb 13, 2026, the Company will redeem: $84,488,000 of the 9.25% Notes and $6,469,000 of the 9.00% Convertible Notes, plus accrued interest.
  • If satisfied after Feb 13, 2026, the trustee will determine amounts so the total redemption payment does not exceed $97,000,000.
  • The 8-K notes this filing itself is not a formal notice of redemption; redemption terms are described in notices distributed to holders by the trustees.

Why It Matters
This action, if completed, would result in the company paying up to $97 million to retire a portion of its secured debt, which directly affects outstanding debt levels and future interest obligations. The redemptions are tied to a separate equity purchase agreement, so completion depends on that transaction; if the deal does not close within the 60-day window the redemption notice is void. Retail investors should watch the equity sale closing and subsequent trustee notices for concrete effects on the company’s capital structure and interest expense.